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Double-Blind Comparative Trial of Parenteral
Lorazepam and Papaveretum in Premedication
A. J. COLEMAN, L. T. BEES
SUMMARY
Lorazepam, a new sedative drug of the benzodiazepine
group, was compared in a double-blind study with a
papaveretumjhyoscine mixture in a series of 50 patients
awaiting surgery.
No difference between the drugs in terms of sedation
or side-effects was detected.
S. Afr. Med. J., 48, 862 (1974).
Lorazepam is a new 1 - 4 benzodiazepine with potent seda-
tive, hypnotic, tranquillising and muscle-relaxant proper-
tes.'-3 The chemistry: pharmacology,' toxicology' and
biotransformation' of lorazepam have been described and
there have been favourable reports of its use as an oral
premedication in surgery."-lO
We compared the premedicant properties of parenteral
lorazepam with those of a papaveretum/hyoscine mixture
(Omnopon and scopolamine).
METHODS
Fifty patients scheduled for elective surgery and clinically
free of neurological or cardiopulmonary disease were in-
vestigated on a double-blind basis. Twenty-five patients re-
ceived lorazepam, and 25 a mixture of papaveretum and
hyoscine. Lorazepam 5 mg, or 20 mg papaveretum and
0,4 mg hyoscine were given, except to 2 patients in each
group. These individuals weighed less than 55 kg and doses
given were therefore halved.
The method of study was similar to that described by
Nisbet and Norris,n,,, Norris and Wallace13 and Norris
and Baird. 14 Patients were first seen in hospital on the day
before operation. Considerable attention was paid to the
patients' comfort and attempts were made to put them at
ease by explanation and reassurance. At the end of the
interview each patient was classified as being either un-
concerned, moderately apprehensive or extremely appre-
hensive about the impending surgery. Heart rate was
measured using a SAN-EI-2D16 pulse meter and a finger
photo-cell. Blood pressure was measured by the standard
auditory method using a sphygmomanometer arm cuff with
attached mercury manometer. The lowest steady heart rate
and blood pressure were noted and served as ward control
measurements.
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On the following day the premedicant drugs were given
by deep injection into the triceps muscle. The patients
were reassessed one hour later in the quiet environment
of an anaesthetic room. Three sets of measurements were
made on each patient, which allowed comparison of find-
ings after premedication with those in the ward, thus
enabling a scoring system to be evolved. Points for 'an-
xiety rating' were awarded thus:




Subjective change in state from ward to anaesthetic
room
Apparent improvement, change in state I - 2, or
2-3 2
No change I
Apparent deterioration, change in state 2 - I 0
Objective change from ward to anaesthetic room
Fall in blood pressure > 10 mmHg 2
No change I
Rise in blood pressure > 10 mmHg 0
Fall in heart rate> 10 beats/min 2
No change I
Rise in heart rate> 10 beats/min 0
Objective change after stimulation (the patient was told
that he was going to be given oxygen to breathe; there-
upon anaesthetic breathing apparatus was gently placed
over the mouth and nose)
Rise in blood pressure > 10 mmHg 0
No change I
Rise in heart rate > 10 beats / min 0
No change I
This gives the maximum possible score of 10, only 4
points of which are dependent on subjective observations.
Patients scoring 0 - 4 were considered poorly sedated,
those scoring 5 and 6 moderately well sedated, those
scoring 7 - 10 well sedated.
Measurement of Forearm Blood Flow
In 10 patients (5 from each group) forearm blood flow
was measured using a mercury-in-Silastic strain-gauge
plethysmograph. The gauge was energised by a model
270 plethysmograph (Parks Electronic). Recordings were
made on a 5" potentiometric recorder (Esterline Angus).
The technique of venous occlusion plethysmography in-
volves the intermittent compression of a cuff placed on
the upper arm which is rapidly inflated from a reservoir
27 April 1974 S.-A. MEDIESE TYDSKRIF 863
TABLE 11. APPREHENSION
TABLE I. SEDATION SCORES
RESULTS






























TABLE IV. PAPAVERETUM AND HYOSCINE
TABLE Ill. LORAZEPAM
0,001). Systolic arterial blood pressure fell significantly,
from a mean value of 125 mmHg to 117,4 mmHg (P<
0,025). After stimulation it increased significantly, to 121,2
mmHg (P<0,001). Forearm blood flow was significantly














Observation control control challenge
Heart rate 72,9 67,0· 72,9~
(beatsjmin)
SO 10,16 11,99 14,46
10 change -8/0 +9%
Systolic blood 125,0 117,4t 121,2t
pressure
(mmHg)
SO 13,92 14,01 16,53
% change -6/0 +3%
Oiastolic blood 79,3 78,3 80,6
pressure
(mmHg)
SO 13,67 9,16 11,43
% change -1% +3/0




Level of significance: • P<O,025; t P<O,010; :: P<O,OO5; ~ P<O,OO1 .
Papaveretum and hyoscine: There were significant de-
creases in both heart rate (P<0,005) and systolic blood
pressure (P<0,OO1) one hour after administration of papa-
veretum and hyoscine. After challenge, heart rate
(P<O,OOI), systolic blood pressure (P<O,01O) and forearm





































Mean Good Fair Poor
Drug (SO) (7 - 10) (5 - 6) (0 - 4)
Lorazepam 7,72 (1,86) 19 3 1
Papavere-
tum and 8,00 (1,89) 20 5 2
hyoscine
to a pressure less than diastolic pressure. This results in ,
swelling or increase in volume of the limb distal to the
cuff. The assumption is made that the swelling is entirely
due to blood inflow and that the rate of swelling equals
the rate of blood flow. In the present study no arterial
occlusion cuff was placed round the wrist. Flow measured
therefore represents both forearm and hand components.
Blood flow was measured every 20 seconds in the
anaesthetic room preceding the 'standard stimulus' and
every 10 seconds thereafter. During the prestimulus con-
trol period, flow measurements were continued until a
'steady state' appeared to exist. The mean of the last 5
readings were taken as the prestimulus forearm blood
flow. After stimulation, measurements were made every
20 seconds for a period of 1t minutes. The peak value
was taken as post-stimulus blood flow. It was assumed
that the forearm blood flow would be increased by fear
and anxiety, and that a well-sedated patient would show
minimal changes after stimulation.
The capacities of the drugs to allay anxiety are illustrated
in Tables I and n. Sedation scores °-4 are considered as
'poor', 5 - 6 'fair', and 7 - 10 'good'. The mean score for
lorazepam (7,72 ± 1,86) was slightly less than that for
papaveretum (8,00 ± 1,89), but in the numbers tested the
difference is not statistically significant. Similarly, when
the drugs are compared with respect to the number of






Lorazepam: The mean heart rate in the ward prior to
administration of lorazepam was 72,9 beats/min. One
hour after lorazepam there was a drop in heart rate to
67,0 beats/min (P<0,025). After challenge there was a
significant increase in heart rate to 72,9 beats/min (P<
11
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Side-Effects
There were no complaints of local reactions, nausea or
vomiting after administration of lorazepam or papavere-
turn and hyoscine. No nausea or vomiting were reported
in the one hour following surgery in this series.
All patients received a 'sleep dose' of thiopentone for
induction of anaesthesia, and were maintained thereafter
on N,O and 0, (70% and 30%) and 1 - 2:% halothane.
Three patients in each group received intubating doses of
a non-depolarising muscle relaxant, pancuronium. No
untoward reactions were noted.
DISCUSSION
Methods of assessing the sedative effects of drugs are
open to criticism. There is much to commend subjective
assessment by the patient, but this method may be in-
validated by influence of the observer, by amnesia, or by
other factors. This has resulted in the frequent use of
scoring systems which make use of both subjective and
objective responses relating to sedation. The results obtain-
ed in this study suggest that pre-operative sedation by
either lorazepam or papaveretum was satisfactory. There
was no difference in the cardiovascular effects of the two
drugs, and no untoward reaction in relation to induction
of anaesthesia, in subsequent maintenance in the operating
theatre, or in postoperative course, was detected.
In conclusion, it would appear that the quality of seda-
tion and the side-effects following lorazepam were similar
to those of papaveretum and hyoscine. There have been
no reports of habituation or addiction associated with
lorazepam; the drug is therefore not subject to the habit-
forming drug restrictions. Lorazepam appears to be an
acceptable alternative premedication to the papaveretum
mixture and merits more extensive clinical trials.
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